Related Experiment Video
Updated: Jun 26, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
Prion protein misfolding and disease
Roger A Moore1, Lara M Taubner, Suzette A Priola
1Rocky Mountain Laboratories, Laboratory of Persistent Viral Diseases, NIAID, NIH, 903 S. 4th Street, Hamilton, MT 59840, United States. rmoore@niaid.nih.gov
Transmissible spongiform encephalopathies (TSEs), or prion diseases, are fatal neurodegenerative disorders caused by misfolded prion proteins (PrP). This review explores the structural basis of prion diseases and their unique transmissibility.
Area of Science:
- Neurodegenerative diseases
- Structural biology
- Mammalian prion biology
Background:
- Transmissible spongiform encephalopathies (TSEs), also known as prion diseases, are fatal neurodegenerative disorders affecting humans and mammals.
- These diseases stem from the misfolding and aggregation of the host prion protein (PrP).
- Prion diseases are unique due to their transmissibility and the existence of distinct strains associated with specific in vivo phenotypes.
Purpose of the Study:
- To review existing structural data for the prion protein (PrP).
- To correlate structural information with the known biology of prion diseases.
- To provide an overview of the molecular underpinnings of prion disease pathogenesis.
Main Methods:
- Literature review of biological and biophysical studies on PrP structure.
- Analysis of existing structural information for PrP.
- Integration of structural data with prion disease biology.
Main Results:
- Evidence suggests that protein conformation encodes the molecular basis of prion diseases.
- Structural insights into PrP aggregation are crucial for understanding disease mechanisms.
- Different PrP conformations may underlie prion disease strain diversity.
Conclusions:
- Prion disease pathogenesis is closely linked to the structural conformation of the prion protein (PrP).
- Understanding PrP structure is key to unraveling the mechanisms of TSEs.
- Further structural studies are essential for developing therapeutic strategies against prion diseases.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Protein Folding
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Protein Folding
Protein Folding
Molecular Chaperones and Protein Folding
The...

